Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 811 | 1,526 | 2,367 | 3,355 | 3,335 |
| TOTAL | $983 | $1,604 | $2,688 | $3,654 | $3,730 |
| Non-Current Assets | |||||
| PPE Net | 93 | 105 | 124 | 154 | 186 |
| Intangibles | 0 | 0 | 2,981 | 5,781 | 5,781 |
| Other Non-Current Assets | 8,151 | 8,851 | 9,851 | 9,851 | 9,851 |
| TOTAL | $8,243 | $8,956 | $12,956 | $15,786 | $15,818 |
| Total Assets | $9,226 | $10,560 | $15,644 | $19,440 | $19,547 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 90 | 57 | 64 | 174 | 232 |
| Accrued Expenses | 256 | 282 | 451 | 399 | 409 |
| Other current liabilities | 22 | 39 | 55 | 102 | 138 |
| TOTAL | $369 | $377 | $569 | $676 | $779 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,056 | 1,020 | 2,430 | 2,339 | 2,624 |
| TOTAL | $4,296 | $4,540 | $6,350 | $6,259 | $6,544 |
| Total Liabilities | $4,665 | $4,918 | $6,919 | $6,935 | $7,323 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 26 | 26 | 26 | N/A |
| Common Shares | 205 | 204 | 204 | 204 | 188 |
| Retained earnings | -115,630 | -114,470 | -111,382 | -107,512 | -107,183 |
| Other shareholders' equity | 2 | 2 | 2 | 2 | 2 |
| TOTAL | $4,561 | $5,642 | $8,725 | $12,505 | $12,225 |
| Total Liabilities And Equity | $9,226 | $10,560 | $15,644 | $19,440 | $19,547 |